These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 912548)

  • 1. Dynamics of osteoclasia in rats with Walker tumor.
    Schäfer A; Raue F; Minne H; Ziegler R
    Calcif Tissue Res; 1977 May; 22 Suppl():368-70. PubMed ID: 912548
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotactic responses of tumor cells to products of resorbing bone.
    Orr W; Varani J; Gondex MK; Ward PA; Mundy GR
    Science; 1979 Jan; 203(4376):176-9. PubMed ID: 569363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of bone loss by denbufylline, an inhibitor of phosphodiesterase 4.
    Miyamoto K; Waki Y; Horita T; Kasugai S; Ohya K
    Biochem Pharmacol; 1997 Sep; 54(5):613-7. PubMed ID: 9337078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat.
    Jung A; Bornand J; Mermillod B; Edouard C; Meunier PJ
    Cancer Res; 1984 Jul; 44(7):3007-11. PubMed ID: 6233002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypercalcemic activity of Walker carcinosarcoma 256 in the rat].
    Minne H; Ziegler R; Schmitt W; Hilgard P
    Schweiz Med Wochenschr; 1971 Apr; 101(13):481-3. PubMed ID: 5558917
    [No Abstract]   [Full Text] [Related]  

  • 6. Pamidronate corrects the down-regulation of the renal parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA in rats bearing Walker tumors.
    Yaghoobian J; Morieux C; Denne MA; Bouizar Z; Ureña P; de Vernejoul MC
    Horm Metab Res; 1998 May; 30(5):249-55. PubMed ID: 9660083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer.
    Powles TJ; Clark SA; Easty DM; Easty GC; Neville AM
    Br J Cancer; 1973 Oct; 28(4):316-21. PubMed ID: 4759939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diphosphonates in the treatment of bone metastases].
    Jung A; Fleisch H
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1878-82. PubMed ID: 6460313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative role of bone and kidney in the hypercalcaemia associated with the rat Walker carcinosarcoma 256.
    Hurtado J; Esbrit P; Rapado A
    Eur J Cancer; 1991; 27(1):76-9. PubMed ID: 1849415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with ibandronate preserves bone in experimental tumour-induced bone loss.
    Kurth AH; Kim SZ; Sedlmeyer I; Hovy L; Bauss F
    J Bone Joint Surg Br; 2000 Jan; 82(1):126-30. PubMed ID: 10697328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Prostaglandins as possible mediators of tumour-induced bone resorption.
    Atkins D; Hunt NH; Martin TJ; Michelangeli VP
    J Physiol; 1976 Jul; 259(1):7P-9P. PubMed ID: 182963
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of parathyroid hormone antagonists to inhibit in vitro bone resorbing activity produced by two animal models of the humoral hypercalcemia of malignancy.
    D'Souza SM; Ibbotson KJ; Mundy GR
    J Clin Invest; 1984 Sep; 74(3):1104-7. PubMed ID: 6470137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone.
    Kostenuik PJ; Singh G; Suyama KL; Orr FW
    Clin Exp Metastasis; 1992 Nov; 10(6):411-8. PubMed ID: 1451351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Walker 256/B carcinosarcoma in thyroparathyroidectomized rats: a model to evaluate inhibitors of bone resorption.
    Rizzoli R; Fleisch H
    Calcif Tissue Int; 1987 Oct; 41(4):202-7. PubMed ID: 2960427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungal osteoclasia: a model of dead bone resorption.
    Marchiafava V; Bonucci E; Ascenzi A
    Calcif Tissue Res; 1974 Mar; 14(3):195-210. PubMed ID: 4843788
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute hypercalcemia due to Walker carcinosarcoma 256 in the rat.
    Hilgard P; Schmitt W; Minne H; Ziegler R
    Horm Metab Res; 1970 Jul; 2(4):255-6. PubMed ID: 5527951
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of a single injection of two new bisphosphonates on the hypercalcemia and hypercalciuria induced by Walker carcinosarcoma 256/B in thyroparathyroidectomized rats.
    Kozak S; Rizzoli R; Trechsel U; Fleisch H
    Cancer Res; 1987 Dec; 47(23):6193-7. PubMed ID: 3677071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alpha tocopherol acetate in Walker 256/B cells-induced oxidative damage in a rat model of breast cancer skeletal metastases.
    Badraoui R; Blouin S; Moreau MF; Gallois Y; Rebai T; Sahnoun Z; Baslé M; Chappard D
    Chem Biol Interact; 2009 Dec; 182(2-3):98-105. PubMed ID: 19781538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analyses of osteoclast changes in resorbing bone organ cultures.
    Rowe DJ; Hausmann E
    Calcif Tissue Res; 1977 Oct; 23(3):283-9. PubMed ID: 902146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and remodeling of bone. An investigation in chicken with special reference to the mechanism of bone resorption.
    Olsson SE
    Acta Radiol Suppl; 1975; 344():13-32. PubMed ID: 60043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.